These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7863250)

  • 1. Acid inhibitory characteristics of nizatidine in man: an overview.
    Parente F; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1994; 206():3-7. PubMed ID: 7863250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early evening nizatidine intake with a meal optimizes the antisecretory effect.
    Duroux P; Emde C; Bauerfeind P; Biollaz J; Armstrong D; Blum AL
    Aliment Pharmacol Ther; 1993 Feb; 7(1):47-54. PubMed ID: 8439637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM; Macdonald AM; McColl KE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
    Thompson A; Kirdeikis P; Jamali F; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
    J Gastroenterol Hepatol; 1995; 10(5):546-54. PubMed ID: 8963030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 24-hour acid suppression profile of nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
    Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion.
    Wajima Z; Shitara T; Inoue T; Yoshikawa T; Ogawa R
    Anaesth Intensive Care; 2000 Feb; 28(1):46-8. PubMed ID: 10701036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an oral evening dose of nizatidine on nocturnal and peptone-stimulated gastric acid and gastrin secretion.
    Kovacs TO; Van Deventer GM; Maxwell V; Sytnik B; Walsh JH
    Scand J Gastroenterol Suppl; 1987; 136():41-6. PubMed ID: 2892254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nizatidine and cisapride increase salivary secretion in rats.
    Adachi K; Furuta K; Katsube T; Fujisawa T; Azumi T; Fujishiro H; Ishihara S; Amano Y; Kinoshita Y
    Dig Dis Sci; 2004 Mar; 49(3):399-403. PubMed ID: 15139487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.
    Fullarton GM; McLauchlan G; Macdonald A; Crean GP; McColl KE
    Gut; 1989 Apr; 30(4):449-54. PubMed ID: 2565860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
    Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
    J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
    Lin TM; Evans DC; Warrick MW; Pioch RP
    J Pharmacol Exp Ther; 1986 Nov; 239(2):406-10. PubMed ID: 2877081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of oral nizatidine.
    Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
    J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
    Neubauer BL; Goode RL; Best KL; Hirsch KS; Lin TM; Pioch RP; Probst KS; Tinsley FC; Shaar CJ
    Toxicol Appl Pharmacol; 1990 Feb; 102(2):219-32. PubMed ID: 1967857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man.
    Boyd EJ; Wormsley KG
    Eur J Clin Pharmacol; 1984; 26(4):443-7. PubMed ID: 6145595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.